Company
Aprea Therapeutics, Inc. (APRE)
Standardized SEC financial data for Aprea Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001781983 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-101.3%
Free cash flow
-$12.9M
Current ratio
5.63×
EPS (diluted)
$-1.93
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $37.9M | $23.9M | $16.4M | $7.6M | $9.4M | $7.0M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $89.0M | $53.1M | $28.8M | $21.6M | $22.9M | $14.6M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$41.8M | -$37.7M | -$25.0M | -$12.2M | -$13.6M | -$12.9M |
| Capital expenditures |
Get APRE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/APRE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/APRE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"